NASDAQ · TSPY
TappAlpha SPY Growth & Daily Income ETF
$24.92-$0.45 (-1.77%)
TappAlpha SPY Growth & Daily Income ETF’s quoted price sits in the upper half of its reported 52-week range, 6.56% below the high.
Loading market information…
AMEX · FMKT · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:53 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
The Free Markets ETF’s quoted price sits in the lower half of its reported 52-week range, 8.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This actively managed exchange-traded fund endeavors to generate returns by investing in U.S.-listed companies poised to benefit from evolving regulatory environments that promote free-market principles. Its primary focus is on industries historically burdened by extensive oversight, such as healthcare, financial services, and energy, anticipating forthcoming regulatory relief. However, the fund also allocates capital to less regulated sectors like technology and consumer goods. The strategy capitalizes on various favorable policy shifts, including reduced government intervention, tax reductions, streamlined licensing procedures, and the elimination of trade barriers. By anticipating these regulatory transformations, the fund aims to uncover undervalued opportunities and mitigate the impact of increasing regulatory burdens elsewhere. Company selection emphasizes evaluating businesses for their potential to capitalize on deregulation, assessing their adaptability, strategic initiatives, and competitive standing within their respective markets. The portfolio typically comprises between 25 and 50 holdings, with at least 80% of its assets dedicated to entities expected to gain from deregulation. Furthermore, up to 5% of the fund's assets may be channeled into exchange-traded products offering exposure to Bitcoin and Ether, thereby diversifying the portfolio and tapping into the growth potential of digital assets.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 06:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$24.92-$0.45 (-1.77%)
TappAlpha SPY Growth & Daily Income ETF’s quoted price sits in the upper half of its reported 52-week range, 6.56% below the high.
$30.66-$0.63 (-2.01%)
iShares Nasdaq-100 ex Top 30 ETF’s quoted price sits in the upper half of its reported 52-week range, 5.92% below the high.
$29.95-$0.46 (-1.51%)
Argent Focused Small Cap ETF’s quoted price sits in the lower half of its reported 52-week range, 10.22% below the high.
$36.55-$0.15 (-0.41%)
DoubleLine Fortune 500 Equal Weight ETF’s quoted price sits in the upper half of its reported 52-week range, 7.97% below the high.
$38.25+$0.45 (+1.19%)
Horizon Kinetics Medical ETF’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
$21.53-$0.28 (-1.26%)
Adaptive Tactical Rotation ETF’s quoted price sits in the upper half of its reported 52-week range, 8.21% below the high.
$36.85-$0.51 (-1.38%)
TrueShares Structured Outcome (March) ETF’s quoted price sits in the upper half of its reported 52-week range, 2.69% below the high.
$42.27-$0.61 (-1.43%)
Innovator U.S. Equity Accelerated Plus ETF - July’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
